首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1968104

全球原代細胞培養市場規模、佔有率、趨勢及成長分析報告（2026-2034年）

Global Primary Cells Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年02月05日 | 出版商:

Value Market Research | 英文 167 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計到 2034 年，原代細胞培養市場規模將從 2025 年的 30.1 億美元成長至 76.3 億美元，2026 年至 2034 年的複合年成長率為 10.9%。

隨著研究人員在藥物研發和疾病研究中越來越依賴生理相關的細胞模型，全球原代細胞培養市場正在擴張。與永生化細胞株相比，原代細胞培養具有更高的生物學精確性，因此對轉化研究至關重要。再生醫學和毒性測試應用領域日益成長的需求也推動了市場的持續成長。

成長要素包括：針對人類相關臨床模型的監管激勵措施、細胞分離和冷凍保存技術的進步，以及個人化醫療研究的擴展。供體特異性和疾病特異性原代細胞培養物的日益普及提高了研究的準確性。供應商與研究機構之間的合作也有助於提高細胞培養物的可及性和產品品質。

未來的成長機會在於與類器官系統、3D培養和微生理平台的整合。臨床應用對符合GMP標準的原代培養細胞的需求預計將會成長。能夠確保符合倫理的採購、認證和可擴展性的供應商將在不斷變化的市場格局中獲得競爭優勢。

區域分析
北美市場分析、洞察與預測
- 美國
- 加拿大
- 墨西哥
歐洲市場分析、洞察與預測
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太市場分析、洞察與預測
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 其他亞太國家
拉丁美洲市場分析、洞察與預測
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他拉丁美洲國家
中東和非洲市場分析、洞察與預測
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他中東和非洲國家

第9章競爭情勢

最新趨勢
公司分類
供應鏈和銷售管道合作夥伴（根據現有資訊）
市場佔有率和市場定位分析（基於現有資訊）
供應商情況（基於現有資訊）
策略規劃

第10章：公司簡介

主要公司的市佔率分析
公司簡介
- Thermo Fisher Scientific
- Merck KGaA
- Lonza
- Cell Biologics Inc
- PromoCell
- ZenBio
- Stemcell Technologies
- AllCells
- American Type Culture Collection
- Axol Biosciences Ltd

簡介目錄

Product Code: VMR112110224

The Primary Cells Market size is expected to reach USD 7.63 Billion in 2034 from USD 3.01 Billion (2025) growing at a CAGR of 10.9% during 2026-2034.

The Global Primary Cells market is expanding as researchers increasingly rely on physiologically relevant cell models for drug discovery and disease research. Primary cells offer improved biological accuracy compared to immortalized cell lines, making them essential for translational studies. Rising demand from regenerative medicine and toxicity testing applications supports consistent market growth.

Growth drivers include regulatory encouragement for human-relevant testing models, improved isolation and cryopreservation techniques, and expansion of personalized medicine research. Increasing availability of donor-specific and disease-state primary cells strengthens research precision. Partnerships between suppliers and research institutions also enhance accessibility and product quality.

Future opportunities lie in integration with organoid systems, 3D cultures, and microphysiological platforms. Demand for GMP-grade primary cells for clinical applications will rise. Suppliers that ensure ethical sourcing, authentication, and scalability will gain competitive advantage in this evolving market landscape.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Origin

Human Primary Cells
Animal Primary Cells

By Type

Hematopoietic Cells
Skin Cells
Hepatocytes
Gastrointestinal Cells
Lung Cells
Renal Cells
Heart Cells
Skeletal and Muscle Cells
Other Primary Cells

By Application

Drug Discovery and Development
Regenerative Medicine
Cancer Research
Others

By End User

Pharmaceuticals & Biotechnology Companies
Academic & Research Institutes
CROs

COMPANIES PROFILED

Thermo Fisher Scientific, Merck KGaA, Lonza, Cell Biologics Inc, PromoCell, ZenBio, Stemcell Technologies, AllCells, American Type Culture Collection, Axol Biosciences Ltd
We can customise the report as per your requirements.

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL PRIMARY CELLS MARKET: BY ORIGIN 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Origin
4.2. Human Primary Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Animal Primary Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRIMARY CELLS MARKET: BY TYPE 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Type
5.2. Hematopoietic Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Skin Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Hepatocytes Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Gastrointestinal Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Lung Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.7. Renal Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.8. Heart Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.9. Skeletal and Muscle Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.10. Other Primary Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRIMARY CELLS MARKET: BY APPLICATION 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Application
6.2. Drug Discovery and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Cancer Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRIMARY CELLS MARKET: BY END USER 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End User
7.2. Pharmaceuticals & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PRIMARY CELLS MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Origin
- 8.2.2 By Type
- 8.2.3 By Application
- 8.2.4 By End User
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Origin
- 8.3.2 By Type
- 8.3.3 By Application
- 8.3.4 By End User
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Origin
- 8.4.2 By Type
- 8.4.3 By Application
- 8.4.4 By End User
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Origin
- 8.5.2 By Type
- 8.5.3 By Application
- 8.5.4 By End User
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Origin
- 8.6.2 By Type
- 8.6.3 By Application
- 8.6.4 By End User
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PRIMARY CELLS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Thermo Fisher Scientific
- 10.2.2 Merck KGaA
- 10.2.3 Lonza
- 10.2.4 Cell Biologics Inc
- 10.2.5 PromoCell
- 10.2.6 ZenBio
- 10.2.7 Stemcell Technologies
- 10.2.8 AllCells
- 10.2.9 American Type Culture Collection
- 10.2.10 Axol Biosciences Ltd